miR-16-5p |
PPM1D |
20668064 |
4 / breast tissue / invasive breast cancer |
883 |
16 |
98.19% = (883–16)/883 |
miR-301a-3p |
PTEN |
21393507 |
4 / breast tissue / invasive breast cancer |
533 |
14 |
97.37% |
miR-195-5p |
SLC2A3 |
22265971 |
3 / bladder tissue / carcinoma of bladder |
3008 |
125 |
95.84% |
miR-615-5p |
IGF2 |
22819824 |
3 / liver tissue / liver neoplasms |
1238 |
57 |
95.40% |
miR-519d-3p |
CDKN1A |
22262409 |
4 / liver tissue / liver neoplasms |
717 |
45 |
93.72% |
miR-135a-5p |
APC |
18632633 |
4 / colon / colorectal neoplasms |
374 |
27 |
92.78% |
miR-153-3p |
MCL1 |
19676043 |
3 / brain / glioblastoma |
1816 |
156 |
91.41% |
miR-204-5p |
EZR |
21416062 |
3 / stomach / stomach carcinoma |
1152 |
104 |
90.97% |
miR-103a-3p |
KLF4 |
22593189 |
3 / colon / colorectal carcinoma |
2095 |
236 |
88.74% |
miR-497-5p |
RAF1 |
21350001 |
4 / breast tissue / breast neoplasms |
887 |
106 |
88.05% |